These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 18250473
1. Transglutaminase type II is involved in the pathogenesis of endotoxic shock. Falasca L, Farrace MG, Rinaldi A, Tuosto L, Melino G, Piacentini M. J Immunol; 2008 Feb 15; 180(4):2616-24. PubMed ID: 18250473 [Abstract] [Full Text] [Related]
2. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. Falasca L, Iadevaia V, Ciccosanti F, Melino G, Serafino A, Piacentini M. J Immunol; 2005 Jun 01; 174(11):7330-40. PubMed ID: 15905580 [Abstract] [Full Text] [Related]
3. Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice. Yoo H, Ahn ER, Kim SJ, Lee SH, Oh SH, Kim SY. Amino Acids; 2013 Jan 01; 44(1):189-97. PubMed ID: 23053022 [Abstract] [Full Text] [Related]
4. Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model. Hong GU, Cho JW, Kim SY, Shin JH, Ro JY. Toxicol Appl Pharmacol; 2018 Nov 01; 358():10-22. PubMed ID: 30195017 [Abstract] [Full Text] [Related]
5. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. Johnson KA, van Etten D, Nanda N, Graham RM, Terkeltaub RA. J Biol Chem; 2003 May 23; 278(21):18824-32. PubMed ID: 12606540 [Abstract] [Full Text] [Related]
6. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling. Sarang Z, Köröskényi K, Pallai A, Duró E, Melino G, Griffin M, Fésüs L, Szondy Z. Immunol Lett; 2011 Jul 23; 138(1):71-8. PubMed ID: 21420434 [Abstract] [Full Text] [Related]
7. Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. Diaz-Hidalgo L, Altuntas S, Rossin F, D'Eletto M, Marsella C, Farrace MG, Falasca L, Antonioli M, Fimia GM, Piacentini M. Biochim Biophys Acta; 2016 Aug 23; 1863(8):2084-92. PubMed ID: 27169926 [Abstract] [Full Text] [Related]
8. Tissue-specific responses to loss of transglutaminase 2. Deasey S, Shanmugasundaram S, Nurminskaya M. Amino Acids; 2013 Jan 23; 44(1):179-87. PubMed ID: 22194042 [Abstract] [Full Text] [Related]
9. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration. van Strien ME, de Vries HE, Chrobok NL, Bol JGJM, Breve JJP, van der Pol SMP, Kooij G, van Buul JD, Karpuj M, Steinman L, Wilhelmus MM, Sestito C, Drukarch B, Van Dam AM. Brain Behav Immun; 2015 Nov 23; 50():141-154. PubMed ID: 26133787 [Abstract] [Full Text] [Related]
10. Characterization of transglutaminase type II role in dendritic cell differentiation and function. Matic I, Sacchi A, Rinaldi A, Melino G, Khosla C, Falasca L, Piacentini M. J Leukoc Biol; 2010 Jul 23; 88(1):181-8. PubMed ID: 20371597 [Abstract] [Full Text] [Related]
11. Regulation of endothelial cell inflammation and lung polymorphonuclear lymphocyte infiltration by transglutaminase 2. Bijli KM, Kanter BG, Minhajuddin M, Leonard A, Xu L, Fazal F, Rahman A. Shock; 2014 Dec 23; 42(6):562-9. PubMed ID: 25057925 [Abstract] [Full Text] [Related]
12. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation. Oh K, Park HB, Seo MW, Byoun OJ, Lee DS. Clin Immunol; 2012 Nov 23; 145(2):122-32. PubMed ID: 23001131 [Abstract] [Full Text] [Related]
13. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Colak G, Johnson GV. Neurobiol Dis; 2012 Mar 23; 45(3):1042-50. PubMed ID: 22198379 [Abstract] [Full Text] [Related]
14. Imaging of the ex vivo transglutaminase activity in liver macrophages of sepsis mice. Su T, Qin XY, Furutani Y, Yu W, Kojima S. Anal Biochem; 2020 May 15; 597():113654. PubMed ID: 32142762 [Abstract] [Full Text] [Related]
15. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. Cecil DL, Terkeltaub R. J Immunol; 2008 Jun 15; 180(12):8378-85. PubMed ID: 18523305 [Abstract] [Full Text] [Related]
16. Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis. Jeong EM, Son YH, Choi Y, Kim JH, Lee JH, Cho SY, Kim IG. Exp Mol Med; 2016 Nov 04; 48(11):e267. PubMed ID: 27811936 [Abstract] [Full Text] [Related]
17. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination. Van Strien ME, Baron W, Bakker EN, Bauer J, Bol JG, Brevé JJ, Binnekade R, Van Der Laarse WJ, Drukarch B, Van Dam AM. Glia; 2011 Nov 04; 59(11):1622-34. PubMed ID: 21818782 [Abstract] [Full Text] [Related]
18. Transglutaminase type II plays a protective role in hepatic injury. Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, Antonucci G, Craxì A, Fimia GM, Iadevaia V, Melino G, Ruco L, Tocci G, Ippolito G, Piacentini M. Am J Pathol; 2003 Apr 04; 162(4):1293-303. PubMed ID: 12651621 [Abstract] [Full Text] [Related]
19. The metastatic tumor antigen 1-transglutaminase-2 pathway is involved in self-limitation of monosodium urate crystal-induced inflammation by upregulating TGF-β1. Yen JH, Lin LC, Chen MC, Sarang Z, Leong PY, Chang IC, Hsu JD, Chen JH, Hsieh YF, Pallai A, Köröskényi K, Szondy Z, Tsay GJ. Arthritis Res Ther; 2015 Mar 19; 17(1):65. PubMed ID: 25889736 [Abstract] [Full Text] [Related]
20. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice. Van Herck JL, Schrijvers DM, De Meyer GR, Martinet W, Van Hove CE, Bult H, Vrints CJ, Herman AG. J Vasc Res; 2010 Mar 19; 47(3):231-40. PubMed ID: 19893320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]